首页> 外文期刊>Frontiers in Medicine >Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade Groups
【24h】

Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade Groups

机译:新前列腺癌国际泌尿外科病理学学会的预后价值

获取原文
       

摘要

Gleason grading is the best independent predictor for prostate cancer (PCa) progression. Recently, a new PCa grading system has been introduced by the International Society of Urological Pathology (ISUP) and is recommended by the World Health Organization (WHO). Following studies observed more accurate and simplified grade stratification of the new system. Aim of this study was to compare the prognostic value of the new grade groups compared to the former Gleason Grading and to determine whether re-definition of Gleason Pattern 4 might reduce upgrading from prostate biopsy to radical prostatectomy (RP) specimen. A cohort of men undergoing RP from 2002 to 2015 at the Hospital of Goeppingen (Goeppingen, Germany) was used for this study. In total, 339 pre-operative prostatic biopsies and corresponding RP specimens, as well as additional 203 RP specimens were re-reviewed for Grade Groups according to the ISUP. Biochemical recurrence-free survival (BFS) after surgery was used as endpoint to analyze prognostic significance. Other clinicopathological data included TNM-stage and pre-operative PSA level. Kaplan–Meier analysis revealed risk stratification of patients based on both former Gleason Grading and ISUP Grade Groups, and was statistically significant using the log-rank test (p < 0.001). Both grading systems significantly correlated with TNM-stage and pre-operative PSA level (p < 0.001). Higher tumor grade in RP specimen compared to corresponding pre-operative biopsy was observed in 44 and 34.5% of cases considering former Gleason Grading and ISUP Grade Groups, respectively. Both, former Gleason Grading and ISUP Grade Groups predict survival when applied on tumors in prostatic biopsies as well as RP specimens. This is the first validation study on a large representative German community-based cohort to compare the former Gleason Grading with the recently introduced ISUP Grade Groups. Our data indicate that the ISUP Grade Groups do not improve predictive value of PCa grading and might be less sensitive in deciphering tumors with 3 + 4 and 4 + 3 pattern on RP specimen. However, the Grade Group system results less frequently in an upgrading from biopsy to the corresponding RP specimens, indicating a lower risk to miss potentially aggressive tumors not represented on biopsies.
机译:格里森分级是前列腺癌(PCa)进展的最佳独立预测因子。最近,国际泌尿外科病理学会(ISUP)引入了一种新的PCa分级系统,并得到世界卫生组织(WHO)的推荐。以下研究发现,新系统的等级分层更加准确和简化。这项研究的目的是比较新等级组与以前的格里森分级的预后价值,并确定重新定义格里森模式4是否会减少从前列腺穿刺活检到根治性前列腺切除术(RP)标本的升级。这项研究使用了2002年至2015年在Goeppingen医院(德国Goeppingen,德国)接受过RP治疗的一组男性。根据ISUP,总共对339个术前前列腺活检标本和相应的RP标本以及另外203个RP标本进行了等级组复查。手术后无生化复发生存(BFS)被用作分析预后的重要指标。其他临床病理数据包括TNM分期和术前PSA水平。 Kaplan–Meier分析显示,根据既往的Gleason分级和ISUP分级组对患者进行风险分层,使用对数秩检验具有统计学意义(p <0.001)。两种分级系统均与TNM分期和术前PSA水平显着相关(p <0.001)。分别考虑先前的Gleason分级和ISUP分级组,分别在44和34.5%的病例中,RP样本的肿瘤分级高于相应的术前活检。当应用于前列腺活检和RP标本中的肿瘤时,以前的Gleason评分组和ISUP评分组均预测生存。这是一项针对大型具有代表性的德国社区队列的首次验证研究,旨在将前格里森分级与最近引入的ISUP等级组进行比较。我们的数据表明,ISUP分级组不能提高PCa分级的预测价值,并且在解密RP标本上具有3 + 4和4 + 3模式的肿瘤时可能不那么敏感。但是,等级组系统导致从活检升级为相应的RP标本的频率降低,从而提示错过活检未显示的潜在侵袭性肿瘤的风险较低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号